Department of Molecular Pharmacology, City of Hope National Medical Center, Duarte, California 91010, USA.
Mol Cancer Ther. 2010 Jun;9(6):1669-79. doi: 10.1158/1535-7163.MCT-10-0023. Epub 2010 May 18.
Ribonucleotide reductase (RNR) is an enzyme for the de novo conversion of ribonucleotides to deoxyribonucleotides. The two human RNR small subunits hRRM2 and hp53R2 share 83% sequence homology but show distinct expression patterns and function. Structural analyses of the oxidized form of hRRM2 and hp53R2 indicate that both proteins contain a conserved Gln127-hp53R2/Gln165-hRRM2 close to the dinuclear iron center and the essential tyrosine residue Tyr124-hp53R2/Tyr162-hRRM2 forms hydrogen bonds with the tyrosine and iron ligands, implying a critical role for the glutamine residue in assembling the dityrosyl-diiron radical cofactor. The present work also showed that Tyr221 in hRRM2, which is replaced by Phe183 in hp53R2, forms a hydrogen bond with Tyr162 to extend the hydrogen bond network from Gln165-hRRM2. Mutagenesis and spectroscopic experiments suggested that the tyrosine-to-phenylalanine switch at Phe183-hp53R2/Tyr221-hRRM2 could lead to differences in radical generation or enzymatic activity for hp53R2 and hRRM2. This study correlates the distinct catalytic mechanisms of the small subunits hp53R2 and hRRM2 with a hydrogen-bonding network and provides novel directions for designing and developing subunit-specific therapeutic agents for human RNR enzymes.
核糖核苷酸还原酶(RNR)是一种将核糖核苷酸转化为脱氧核糖核苷酸的酶。两种人类 RNR 小亚基 hRRM2 和 hp53R2 具有 83%的序列同源性,但表现出不同的表达模式和功能。对氧化形式的 hRRM2 和 hp53R2 的结构分析表明,这两种蛋白质都包含一个保守的 Gln127-hp53R2/Gln165-hRRM2 靠近双核铁中心和必需的酪氨酸残基 Tyr124-hp53R2/Tyr162-hRRM2 与酪氨酸和铁配体形成氢键,表明谷氨酰胺残基在组装二酪氨酸-二铁自由基辅因子中起着关键作用。本工作还表明,hRRM2 中的 Tyr221 被 hp53R2 中的 Phe183 取代,与 Tyr162 形成氢键,从而扩展了 Gln165-hRRM2 的氢键网络。突变和光谱实验表明,hp53R2 和 hRRM2 中的 Tyr221 到 Phe183 的酪氨酸到苯丙氨酸的转变可能导致 hp53R2 和 hRRM2 的自由基生成或酶活性的差异。这项研究将小亚基 hp53R2 和 hRRM2 的不同催化机制与氢键网络联系起来,为设计和开发针对人类 RNR 酶的亚基特异性治疗剂提供了新的方向。